About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Pharmaceutical Preparation Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 247.9 M 2.47865E+08 234 234 0.12% 0.00121622 637 K 636720
UBIO Proshares UltraPro Nasdaq Biotechnology 31.1 M 3.10775E+07 228 228 0.07% 0.000701688 71 K 71404
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.02% 0.000191621 63 K 63058
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.03% 0.000284636 113 K 113183
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.44033E+09 2,002 2002 0.01% 0.000139 198 K 198023
VHT Vanguard Health Care ETF 9.4 B 9.400001E+09 361 361 0.05% 0.00047 4.4 M 4446240
VTWG Vanguard Russell 2000 Growth ETF 286.3 M 2.863E+08 1,245 1245 0.16% 0.00156 445 K 445454
VTWO Vanguard Russell 2000 ETF 1.6 B 1.6E+09 2,013 2013 0.08% 0.00079 1.3 M 1276700
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.24908E+09 222 222 0.26% 0.0026 22.6 M 2.25906E+07
IHE iShares U.S. Pharmaceutical ETF 388.4 M 3.88423E+08 44 44 0.76% 0.0076 3.0 M 2969980
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.01% 0.0001 1.2 M 1218630
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.08% 0.0008 34.4 M 3.44406E+07
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.15% 0.0015 13.9 M 1.38653E+07
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.01% 0.0001 538 K 537502
JKK iShares Morningstar Small-Cap Growth ETF 203.7 M 2.03656E+08 245 245 0.29% 0.0029 585 K 584694
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 354 354 0.05% 0.00045145 728 K 727730
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.0 B 2E+09 1,005 1005 0.02% 0.000228794 451 K 450741

Wait, Before You Leave...